Overview

• AstraZeneca plans to launch 20 new drugs to achieve its ambitious revenue goal.
• The company aims to leverage its oncology and rare disease portfolios for significant growth.
• Investment in advanced technologies like antibody-drug conjugates and radiopharmaceuticals is a key strategy.
• AstraZeneca has ceased production of its COVID-19 vaccine due to reduced demand.
• A new $1.5 billion manufacturing facility in Singapore will support the production of innovative cancer treatments.